Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01522404
Recruitment Status : Completed
First Posted : January 31, 2012
Last Update Posted : August 6, 2018
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Allan I Levey, MD, Emory University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 31, 2017
  Actual Study Completion Date : June 30, 2018